Microdosing Studies Under Development

Amanda Feilding is convinced of the benefits that microdosing may offer to older individuals, particularly those suffering from a neurodegenerative disorder, or undergoing palliative care.

The Beckley Foundation is currently developing several studies whose aims will be to evaluate the potential of psychedelics microdosing to enhance wellbeing and vitality and reduce cognitive decline in ageing.

These effects could be beneficial in the prevention and treatment of a number of age-related conditions.

  • Chronic pain
  • Inflammatory diseases
  • End-of-life depression and anxiety
  • Neurodegeneration

In healthy individuals, boosting these functions may also have numerous positive effects.

  • Prevention of cognitive decline
  • Longevity
  • Mood and vitality enhancement
  • Flexibility and resilience